Dyne Therapeutics Inc (DYN)
26.02
+0.06
(+0.23%)
USD |
NASDAQ |
May 10, 16:00
26.02
0.00 (0.00%)
After-Hours: 20:00
Dyne Therapeutics Total Assets (Quarterly): 522.28M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 522.28M |
December 31, 2023 | 165.08M |
September 30, 2023 | 205.24M |
June 30, 2023 | 251.42M |
March 31, 2023 | 288.64M |
December 31, 2022 | 306.32M |
September 30, 2022 | 299.68M |
June 30, 2022 | 340.03M |
March 31, 2022 | 387.76M |
Date | Value |
---|---|
December 31, 2021 | 425.66M |
September 30, 2021 | 466.88M |
June 30, 2021 | 467.15M |
March 31, 2021 | 491.71M |
December 31, 2020 | 353.33M |
September 30, 2020 | 381.47M |
June 30, 2020 | 146.77M |
December 31, 2019 | 16.44M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
16.44M
Minimum
Dec 2019
522.28M
Maximum
Mar 2024
324.46M
Average
340.03M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
Solid Biosciences Inc | 164.94M |
Sana Biotechnology Inc | 681.38M |
Tenaya Therapeutics Inc | 170.52M |
Prime Medicine Inc | 193.85M |
CEL-SCI Corp | 28.71M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 44.22M |
Shareholders Equity (Quarterly) | 478.06M |